NewAmsterdam Pharma (NAMS) Operating Margin (2023 - 2026)
NewAmsterdam Pharma's Operating Margin was -1752.61% in Q2 2026, down 1566.48 percentage points from -186.13% a year earlier but up 169.10 percentage points from the prior quarter.
NewAmsterdam Pharma (NAMS) Operating Margin (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, NewAmsterdam Pharma's Operating Margin was -3432.20% through Jun 30, 2026, down 3162.24 percentage points year-over-year; for FY2025, it came in at -1002.90%, down 615.99 percentage points from FY2024.
- Operating Margin shows a three-year change of -999.44 percentage points (FY2022 to FY2025).
- In earlier years, Operating Margin was -386.91% in FY2024 (+911.65 pp), -1298.56% in FY2023 (-1295.10 pp) and -3.46% in FY2022.
- Quarterly Operating Margin has moved between -206187.50% (Q4 2025) and -85.89% (Q3 2024) over five years.
- Compared with a year earlier, Operating Margin was higher in five of the last eight quarters, with an average year-over-year change of -26424.37 percentage points.
- The best year-over-year quarter for Operating Margin over five years was Q4 2024 (a gain of 6021.93 percentage points); the worst was Q4 2025 (a drop of 205849.03 percentage points).
- Per Business Quant data, NAMS's Operating Margin in the three quarters before Q2 2026 was -1921.71% (Q1 2026), -206187.50% (Q4 2025) and -15845.69% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | -1,752.61% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,752.61% |
| Mar 31, 2026 | -1,921.71% |
| Dec 31, 2025 | -206,187.50% |
| Sep 30, 2025 | -15,845.69% |
| Jun 30, 2025 | -186.13% |
| Mar 31, 2025 | -2,314.47% |
| Dec 31, 2024 | -338.47% |
| Sep 30, 2024 | -85.89% |
| Jun 30, 2024 | -2,306.93% |
| Mar 31, 2024 | -3,960.17% |
| Dec 31, 2023 | -6,360.40% |
| Sep 30, 2023 | -1,685.07% |
| Jun 30, 2023 | -2,474.20% |
| Mar 31, 2023 | -461.85% |
NewAmsterdam Pharma Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();